Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Steven D. Hughes"'
Autor:
Cecile M Krejsa, Rick D Holly, Mark Heipel, Ken M Bannink, Rebecca Johnson, Richard Roque, Jane Heffernan, Julie Hill, Lay Chin, Felecia Wagener, Faith Shiota, Katherine Henderson, Pallavur V Sivakumar, Hong-Ping Ren, Fariba Barahmand-Pour, Don Foster, Chris Clegg, Wayne Kindsvogel, Rafael Ponce, Steven D Hughes, Kim Waggie
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e67256 (2013)
Rituximab, a monoclonal antibody targeting CD20 on B cells, is currently used to treat many subtypes of B cell lymphomas. However, treatment is not curative and response rates are variable. Recombinant interleukin-21 (rIL-21) is a cytokine that enhan
Externí odkaz:
https://doaj.org/article/75eba1524ef24901bc6062fdb1f8b56a
Autor:
Michael G. Dodds, Klaus Stensgaard Frederiksen, John A. Thompson, Kresten Skak, Steven D. Hughes, Dorthe Lundsgaard, Lasse Hansen
Publikováno v:
Cancer Immunology, Immunotherapy. 58:843-854
Recombinant interleukin-21 (rIL-21) is an immune stimulating cytokine recently tested in two Phase 1 trials for immune responsive cancers. A secondary objective of these trials was to characterize pharmacodynamic responses to rIL-21 in patients. Here
Autor:
Guihua Jiang, Alfred E. Chang, Qiao Li, Takekazu Iuchi, Jianhua Huang, Steven D. Hughes, Mu Li, Bruce G. Redman, Seagal Teitz-Tennenbaum
Publikováno v:
Cancer Research. 68:4431-4441
Interleukin (IL)-21 modulates T-cell–associated, B-cell–associated, and natural killer cell–associated immunity. However, the potential of IL-21 to simultaneously stimulate cellular and humoral antitumor responses and the mechanisms involved ha
Autor:
Edward M. Rubin, Steven D. Hughes
Publikováno v:
Clinical Genetics. 52:361-366
Despite the importance of lipoprotein(a) [Lp(a)] as an atherogenic risk factor, very little information, especially from in vivo studies, is available concerning which structural features of apo(a) contribute to the interactions of Lp(a) with the ves
Autor:
Dorthe Lundsgaard, Lasse Hansen, Grant A. McArthur, Ian D. Davis, Thomas Lindebo Holm, Andreas Petri, Klaus Stensgaard Frederiksen, Brite K Skrumsager, Jeremy A Freeman, Steven D. Hughes, Kresten Skak
Publikováno v:
Cancer Immunology, Immunotherapy
Purpose Human interleukin-21 (IL-21) is a class I cytokine previously reported in clinical studies on immune responsive cancers. Here we report the effects of systemic IL-21 therapy on the immune system in two phase 1 trials with this novel cytokine.
Autor:
Matthew Yeh, Steven D. Hughes, Hong-Ping Ren, Thomas E. Palmer, Melissa M. Odell, Jean S. Campbell, Renay L. Bauer, Debra G. Gilbertson, Harald S. Haugen, Aaron C. Haran, Nelson Fausto, Matthew S. Holdren
Publikováno v:
Proceedings of the National Academy of Sciences. 102:3389-3394
Members of the platelet-derived growth factor (PDGF) ligand family are known to play important roles in wound healing and fibrotic disease. We show that both transient and stable expression of PDGF-C results in the development of liver fibrosis consi
Autor:
Edward M. Rubin, John R. Morrison, Trudy M. Forte, Steven D. Hughes, Chris Paszty, Mary E. Stevens, James Scott
Publikováno v:
Proceedings of the National Academy of Sciences. 93:7154-7159
RNA editing in the nucleus of higher eukaryotes results in subtle changes to the RNA sequence, with the ability to effect dramatic changes in biological function. The first example to be described and among the best characterized, is the cytidine-to-
Autor:
Kelly Byrnes-Blake, Matthew S. Holdren, Susan Pedersen, Dennis M. Miller, Rafael Ponce, Steven D. Hughes, Kimberly S Waggie
Publikováno v:
International journal of toxicology. 31(4)
Interleukin-21 (IL-21), a pleiotropic immunostimulatory type I cytokine, has anticancer effects in animal models. Preclinical studies designed to assess the safety of recombinant human IL-21 (rIL-21) for use in phase I oncology studies are described.
Publikováno v:
Journal of Biological Chemistry. 268:15205-15212
Glucose is thought to stimulate insulin release from islet beta-cells through generation of metabolic signals. In the current study we have introduced the genes encoding the facilitated glucose transporters known as GLUT-1 and GLUT-2 into AtT-20ins c
Autor:
Christopher B. Newgard, Steven D. Hughes, Lindsey R. Inman, Ling Chen, John H. Johnson, Roger H Unger, Chris T. Mcallister, John R. Kettman
Publikováno v:
Proceedings of the National Academy of Sciences. 90:1281-1284
Purified immunoglobulin G (IgG) from the serum of patients with insulin-dependent diabetes mellitus (IDDM) of recent onset inhibits high-Km uptake of 3-O-methyl-beta-D-glucose by rat pancreatic islets. To determine if the inhibition is the result of